425 related articles for article (PubMed ID: 31781301)
1. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
Chen Y; Jin M; Shao Y; Xu G
Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
3. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
4. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
[No Abstract] [Full Text] [Related]
5. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
Zhang L; Su Y; Chen Z; Wei Z; Han W; Xu A
Medicine (Baltimore); 2017 Jul; 96(30):e7647. PubMed ID: 28746229
[TBL] [Abstract][Full Text] [Related]
6. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
8. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.
Geng Y; Shao Y; Zhu D; Zheng X; Zhou Q; Zhou W; Ni X; Wu C; Jiang J
Sci Rep; 2016 Dec; 6():39482. PubMed ID: 28000729
[TBL] [Abstract][Full Text] [Related]
9. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
Han WX; Chen ZM; Wei ZJ; Xu AM
World J Surg Oncol; 2016 Nov; 14(1):279. PubMed ID: 27809860
[TBL] [Abstract][Full Text] [Related]
10. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.
Du R; Ming J; Geng J; Zhu X; Zhang Y; Li S; Liu Z; Wang H; Wang Z; Tang L; Zhang X; Wu A; Bu Z; Yan Y; Li Z; Li Y; Li Z; Wang W
Radiat Oncol; 2022 Mar; 17(1):45. PubMed ID: 35241109
[TBL] [Abstract][Full Text] [Related]
11. Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review.
Tianxing G; Xiaojie P; Lihuan Z; Yangyun H
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31511434
[TBL] [Abstract][Full Text] [Related]
12. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
13. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
[TBL] [Abstract][Full Text] [Related]
15. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
[TBL] [Abstract][Full Text] [Related]
18. Association of systemic inflammation and body mass index with survival in patients with resectable gastric or gastroesophageal junction adenocarcinomas.
Gao X; Pan Y; Han W; Hu C; Wang C; Chen L; Guo Y; Shi Y; Pan Y; Xie H; Yao L; Yang J; Zheng J; Li X; Liu X; Hong L; Li J; Li M; Ji G; Li Z; Xia J; Zhao Q; Fan D; Wu K; Nie Y
Cancer Biol Med; 2021 Feb; 18(1):283-297. PubMed ID: 33628601
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
Liu JF; Jiang T; Shi ZH; Liu XB
ANZ J Surg; 2018 Mar; 88(3):218-222. PubMed ID: 27444989
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
